Results 181 to 190 of about 24,285 (259)

Conformational landscape of HIV-1 Env from closed to fully open. [PDF]

Nat Commun
Cui J, Lin ZJ, Ghosh S, Du J, Sadeesh R, Weiner DB, Pallesen J.   +6 more
europepmc   +1 more source

HIV gp41 fusion peptide increases membrane ordering in a cholesterol-dependent fashion.

Biophysical Journal, 2014
A. Lai, J. Freed
semanticscholar   +1 more source

Dissociation of the trimeric gp41 ectodomain at the lipid–water interface suggests an active role in HIV-1 Env-mediated membrane fusion

Proceedings of the National Academy of Sciences of the United States of America, 2014
Julien Roche, J. Louis, A. Grishaev, J. Ying, A. Bax   +4 more
semanticscholar   +1 more source

Trimeric Class I Viral Fusion Protein Vaccine Immunogens Using a Trimeric Autotransporter in a Killed Whole-Cell Bacteria Vaccine Platform: Applications to HIV MPER. [PDF]

Viruses
Quintero-Barbosa JS, Song Y, Mehl F, Mathur S, Livingston L, Shen X, Montefiori DC, Zeichner SL.   +7 more
europepmc   +1 more source

Structure of an HIV-1–neutralizing antibody target, the lipid-bound gp41 envelope membrane proximal region trimer

Proceedings of the National Academy of Sciences of the United States of America, 2014
P. Reardon, H. Sage, S. Dennison, Jeffrey W. Martin, B. Donald, S. Alam, B. Haynes, L. Spicer   +7 more
semanticscholar   +1 more source

Characterization of full-length and cytoplasmic tail-truncated envelope glycoproteins incorporated into human immunodeficiency virus (HIV-1) virions and virus-like particles. [PDF]

J Virol
Anang S, Zhang S, Ennis A, Ding H, Deshpande A, Nguyen HT, Kappes JC, Sodroski JG.   +7 more
europepmc   +1 more source

Genotypic and phenotypic characteristics of CXCR4-using transmitted/founder HIV-1 envelope glycoproteins. [PDF]

J Virol
Martres D, Montagné T, Pani S, Jeanne N, Armani-Tourret M, Requena M, Vellas C, Raymond S, Lorin V, Gallois Y, Puissant-Lubrano B, Mouquet H, Delobel P, Izopet J, Lagane B.   +14 more
europepmc   +1 more source

DNA electroporation of HIV Env elicits robust T cell responses and memory B cell responses with muted serum antibody levels that can be boosted with recombinant protein. [PDF]

Vaccine
De Rosa SC, Gravett RM, Hahn WO, Villaran M, Huang Y, Schmitzberger L, Montefiori D, Domin E, Tomaras GD, Heptinstall J, Seaton KE, Ferrari G, Ozorowski G, Ward AB, Lee WH, van der Maas L, Polakowski L, Frank I, Tieu HV, Kalams SA, Garcia NMG, Huang J, Ghosh S, Purwar M, Kulp D, Humeau L, Kwong PD, McElrath MJ, Corey L, Weiner D, HVTN 304 Study Team.   +30 more
europepmc   +1 more source

Genotypic challenges in implementing broadly neutralizing antibody-based long-acting HIV-1 therapies. [PDF]

Commun Med (Lond)
Tao K, Herschhorn A, Fera D, Lynch RM, Julg BD, Korber B, Shafer RW.   +6 more
europepmc   +1 more source

Decoding the glycan shield: Immune recognition and response to the HIV-1 envelope trimer. [PDF]

J Biol Chem
Nawaz FZ, Adams TM, Demirturk ME, Avci FY.   +3 more
europepmc   +1 more source